UA RU EN

Creatine Boosts Immune System to Fight Cancer, New Study Reveals

Креатин підсилює захисні функції організму в боротьбі з онкологічними захворюваннями, свідчать результати нового дослідження. Photo: НВ — Техно

Exploring Creatine's Impact on Immune Response

Published in iScience on July 8, 2023, a study demonstrated that creatine activates dendritic cells—key immune cells capable of recognizing tumors. The research, conducted on mice with melanoma and human cells, confirmed creatine's effectiveness in stimulating immune responses. However, the work remains in early stages, with no clinical trials on humans conducted so far. The University of California has filed a patent application based on these findings.

Creatine-activated dendritic cells guide killer T-cells to destroy tumors. In mouse experiments, dendritic cells within tumors showed increased activity of the creatine transporter gene. Conversely, artificially removing this transporter from cells eliminated their ability to prepare T-cells for attack. Daily creatine injections in melanoma mice slowed tumor growth and boosted the number of active dendritic cells.

This discovery offers a potential new avenue for enhancing cancer immunotherapy, a field that has gained significant attention in recent years.

Creatine's Promise in Oncology

According to the study, creatine raises ATP levels in immune cells, potentially improving their function. Experiments with human cells confirmed creatine's efficacy, as it enhanced the activation of human dendritic cells used in developing anti-cancer vaccines.

“Creatine doesn’t just help individual cells; it reboots the entire infrastructure that coordinates the immune response.”

Professor Lili Yang, lead author of the study

Co-author James Elsten-Brown added that 'the supplement can be applied in two ways: to support patients during immunotherapy and to improve the quality of anti-tumor vaccines before they are administered into the body.'

These findings open new possibilities for using creatine to enhance immune responses against tumors, though further research and human clinical trials remain necessary to validate these conclusions. Recognizing creatine's potential in oncology could mark a significant step toward developing novel therapeutic strategies that may transform cancer treatment approaches.

While creatine shows promise in enhancing immune responses against cancer, its effects on mental health remain less clear. Recent research indicates that creatine may not effectively alleviate symptoms of depression, raising questions about its overall benefits. Understanding these contrasting effects is crucial for those considering creatine for various health applications.